1. Treatment Optimization in Patients Co-Infected with HIV and Mycobacterium tuberculosis Infections: Focus on Drug–Drug Interactions with Rifamycins

   • Mario Regazzi
   • Anna Cristina Carvalho
   • Alberto Matteelli

   Review Article 29 April 2014 Pages: 489 - 507

2. Sex Differences in the Pharmacokinetics of Antidepressants: Influence of Female Sex Hormones and Oral Contraceptives

   • Valérie A. Damoiseaux
   • Johannes H. Proost
   • Barbro N. Melgert

   Review Article 24 May 2014 Pages: 509 - 519

   

3. Consequences of Renal Failure on Non-Renal Clearance of Drugs

   • Laure Lalande
   • Bruno Charpiat
   • Michel Tod

   Review Article 27 May 2014 Pages: 521 - 532

4. Population Pharmacokinetics and Prediction of Dopamine D₂ Receptor Occupancy After Multiple Doses of RBP‐7000, a New Sustained‐Release Formulation of Risperidone, in Schizophrenia Patients on Stable Oral Risperidone Treatment

   • Celine M. Laffont
   • Roberto Gomeni
   • Azmi F. Nasser

   Original Research Article 24 January 2014 Pages: 533 - 543

   

5. Pharmacokinetics of Indomethacin in Pregnancy

   • Erik Rytting
   • Tatiana N. Nanovskaya
   • Mahmoud S. Ahmed

   Original Research Article 04 February 2014 Pages: 545 - 551

   

6. Evidence-Based Morphine Dosing for Postoperative Neonates and Infants

   • Elke H. J. Krekels
   • Dick Tibboel
   • Catherijne A. J. Knibbe

   Original Research Article 05 February 2014 Pages: 553 - 563

   

7. Determination of an Optimal Dosing Regimen for Fexinidazole, a Novel Oral Drug for the Treatment of Human African Trypanosomiasis: First-in-Human Studies

   • Antoine Tarral
   • Séverine Blesson
   • Nathalie Strub-Wourgaft

   Original Research Article Open access 18 February 2014 Pages: 565 - 580